Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Commercially Available Cannabis (Hemp) Products for Immune Support: A Prospective Observational Study to Evaluate Safety and Effects

NCT05944705 is registered in ClinicalTrials.gov with Center For Interventional Pain and Spine as lead sponsor.

NCT NCT05944705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Commercially Available Cannabis (Hemp) Products for Immune Support: A Prospective Observational Study to Evaluate Safety and Effects
Lead sponsor
Center For Interventional Pain and Spine
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2023
Completion date
December 1, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, covid-19, influenza